June 9, 2023 Comments Off on New patent for Glaxosmithkline drug ARNUITY ELLIPTA Posted in: Patent Added Annual Drug Patent Expirations for ARNUITY+ELLIPTA Arnuity Ellipta is a drug marketed by Glaxosmithkline and is included in one NDA. It is available from one supplier. There are six patents…
The post New patent for Glaxosmithkline drug ARNUITY ELLIPTA …
June 9, 2023 Comments Off on New patent for Glaxo Grp drug BREO ELLIPTA Posted in: Patent Added Annual Drug Patent Expirations for BREO+ELLIPTA Breo Ellipta is a drug marketed by Glaxo Grp Ltd and is included in one NDA. It is available from two suppliers. There are…
The post New patent for Glaxo Grp drug BREO ELLIPTA appeared first on DrugPatent…
